These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 12715722

  • 1. [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
    Zoń-Giebel A, Kotulska A, Giebel S, Cader SA, Kucharz EJ.
    Przegl Lek; 2002; 59(11):916-8. PubMed ID: 12715722
    [Abstract] [Full Text] [Related]

  • 2. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
    Furst DE.
    Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
    [Abstract] [Full Text] [Related]

  • 3. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB, 990145 Study Group.
    Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
    [Abstract] [Full Text] [Related]

  • 4. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
    Cohen SB.
    Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
    [Abstract] [Full Text] [Related]

  • 5. Anakinra: new preparation. Weakly effective in rheumatoid arthritis.
    Prescrire Int; 2004 Apr; 13(70):43-5. PubMed ID: 15148945
    [Abstract] [Full Text] [Related]

  • 6. [Interleukin-1 receptor antagonist anakinra (Kineret) for treatment of rheumatic arthritis].
    Rubbert-Roth A, Perniok A.
    Z Rheumatol; 2003 Aug; 62(4):367-77. PubMed ID: 12928941
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
    Jiang Y, Genant HK, Watt I, Cobby M, Bresnihan B, Aitchison R, McCabe D.
    Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552
    [Abstract] [Full Text] [Related]

  • 8. [Anakinra for therapy of rheumatoid arthritis].
    Tomoo T, Sumida T.
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():534-7. PubMed ID: 15799413
    [No Abstract] [Full Text] [Related]

  • 9. Bringing the clinical experience with anakinra to the patient.
    Cohen SB, Rubbert A.
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii36-40. PubMed ID: 12817094
    [Abstract] [Full Text] [Related]

  • 10. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
    Fleischmann RM, Schechtman J, Bennett R, Handel ML, Burmester GR, Tesser J, Modafferi D, Poulakos J, Sun G.
    Arthritis Rheum; 2003 Apr; 48(4):927-34. PubMed ID: 12687534
    [Abstract] [Full Text] [Related]

  • 11. Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
    Tesser J, Fleischmann R, Dore R, Bennett R, Solinger A, Joh T, Modafferi D, Schechtman J, 990757 Study Group.
    J Rheumatol; 2004 Apr; 31(4):649-54. PubMed ID: 15088288
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist].
    Suzuki T.
    Nihon Rinsho; 2002 Dec; 60(12):2397-400. PubMed ID: 12510368
    [Abstract] [Full Text] [Related]

  • 13. Addressing the safety of anakinra in patients with rheumatoid arthritis.
    Fleischmann RM.
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii29-35. PubMed ID: 12817093
    [Abstract] [Full Text] [Related]

  • 14. Anakinra: a review of its use in the management of rheumatoid arthritis.
    Waugh J, Perry CM.
    BioDrugs; 2005 May; 19(3):189-202. PubMed ID: 15984903
    [Abstract] [Full Text] [Related]

  • 15. [Anakinra in the treatment of rheumatoid arthritis].
    Loft AG, Tarp U, Thomsen BS.
    Ugeskr Laeger; 2003 Sep 22; 165(39):3720-4. PubMed ID: 14558384
    [No Abstract] [Full Text] [Related]

  • 16. Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy.
    Cohen SB, Strand V, Aguilar D, Ofman JJ.
    Rheumatology (Oxford); 2004 Jun 22; 43(6):704-11. PubMed ID: 14997006
    [Abstract] [Full Text] [Related]

  • 17. Anakinra treatment of patients with rheumatoid arthritis.
    Calabrese LH.
    Ann Pharmacother; 2002 Jun 22; 36(7-8):1204-9. PubMed ID: 12086555
    [Abstract] [Full Text] [Related]

  • 18. Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis.
    Kary S, Burmester GR.
    Int J Clin Pract; 2003 Apr 22; 57(3):231-4. PubMed ID: 12723729
    [Abstract] [Full Text] [Related]

  • 19. [Recommendations of the Deutschen Gesellschaft für Rheumatologie on therapy of rheumatoid arthritis with the interleukin-1-receptor-antagonist Akakinra (KINERET)].
    Manger B, Kommission Pharmakotherapie, Deutschen Gesellschaft für Rheumatologie.
    Z Rheumatol; 2002 Dec 22; 61(6):698-700. PubMed ID: 12491134
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A, McAbee T, Sennello G, Frazier J, Chlipala E, McCabe D.
    Arthritis Rheum; 1999 Mar 22; 42(3):498-506. PubMed ID: 10088773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.